Short and Medium Chain Fatty Acids in a Cohort of Naïve Multiple Sclerosis Patients: Pre- and Post-Interferon Beta Treatment Assessment. [PDF]
Barcutean L +5 more
europepmc +1 more source
Lower leukocytes pretreatment as a possible risk factor for therapy-induced leukopenia in interferon-beta-treated patients with multiple sclerosis. [PDF]
Protopapa M +6 more
europepmc +1 more source
Humoral and Cellular Immunity After Vaccination Against SARS-CoV-2 in Relapsing-Remitting Multiple Sclerosis Patients Treated with Interferon Beta and Dimethyl Fumarate. [PDF]
Bazylewicz M +10 more
europepmc +1 more source
The effect of interferon beta on quality of life in patients with multiple sclerosis: A systematic review and meta-analysis study. [PDF]
Jamshidi M +9 more
europepmc +1 more source
Comparative efficacy of diroximel fumarate, ozanimod and interferon beta-1a for relapsing multiple sclerosis using matching-adjusted indirect comparisons. [PDF]
Jiang T +7 more
europepmc +1 more source
Tumoral Interferon Beta Induces an Immune-Stimulatory Phenotype in Tumor-Associated Macrophages in Melanoma Brain Metastases. [PDF]
Gellert J +11 more
europepmc +1 more source

